EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

EI

281.1

+0.25%↑

SAN

86.18

+1.07%↑

MRK1

119.3

-0.83%↓

SHL.DE

47.04

+1.1%↑

UCB

251

+1.29%↑

Search

BioMerieux

Deschisă

SectorSănătate

116 0.61

Rezumat

Modificarea prețului

24h

Curent

Minim

115.4

Maxim

116.3

Indicatori cheie

By Trading Economics

Venit

-56M

161M

Vânzări

1.3B

2B

P/E

Medie Sector

35.346

35.739

Randament dividend

0.8

Marjă de profit

7.877

Angajați

14,147

EBITDA

314M

476M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+11.35% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.80%

3.08%

Statistici piață

By TradingEconomics

Capitalizare de piață

-177M

13B

Deschiderea anterioară

115.39

Închiderea anterioară

116

Sentimentul știrilor

By Acuity

48%

52%

143 / 371 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

BioMerieux Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 apr. 2025, 08:49 UTC

Principalele dinamici ale pieței

BioMerieux Shares Fall After Warning on Currency-Exchange Hit

Comparație

Modificare preț

BioMerieux Așteptări

Obiectiv de preț

By TipRanks

11.35% sus

Prognoză pe 12 luni

Medie 128.5 EUR  11.35%

Maxim 140 EUR

Minim 120.5 EUR

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruBioMerieux - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

5 ratings

2

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

113.1 / 118.6Suport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

143 / 371 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre BioMerieux

bioMérieux S.A. develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemaseproducing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO BACT/ALERT 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction (PCR) system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated Identification and antimicrobial susceptibility testing (AST) system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST Gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDASB·R·A·H·M·S PCTTM, a specific marker of severe bacterial infections/sepsis. It also provides Biomérieux vision suite, a software that provides actionable information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE Monoplex PCR tests; NUCLISENS ranges, a product for automation of the molecular biology laboratory and extraction; EMAG system For DNA and RNA extraction; ESTREAM, an automated preparation station for samples to process PCR tests; GENE-UP and VERIFLOW ranges for detection of microorganisms for the food industry. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
help-icon Live chat